ValuEngine lowered shares of Cavium (NASDAQ:CAVM) from a hold rating to a sell rating in a research note issued to investors on Thursday morning.

A number of other research firms have also commented on CAVM. Zacks Investment Research lowered shares of Cavium from a hold rating to a sell rating in a research report on Tuesday, January 2nd. Stifel Nicolaus boosted their price target on shares of Cavium from $68.00 to $81.00 and gave the company a hold rating in a research report on Thursday, February 1st. Raymond James lowered shares of Cavium from an outperform rating to a market perform rating and set a $80.00 price target for the company. in a research report on Friday, February 2nd. Finally, BidaskClub lowered shares of Cavium from a hold rating to a sell rating in a research report on Wednesday, April 4th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and seven have issued a buy rating to the stock. Cavium has an average rating of Hold and an average price target of $79.33.

Shares of CAVM stock opened at $77.13 on Thursday. The company has a current ratio of 2.80, a quick ratio of 2.26 and a debt-to-equity ratio of 0.78. Cavium has a 1 year low of $56.96 and a 1 year high of $92.66. The firm has a market cap of $5,387.45, a price-to-earnings ratio of 53.94, a price-to-earnings-growth ratio of 1.93 and a beta of 1.34.

Cavium (NASDAQ:CAVM) last issued its earnings results on Wednesday, January 31st. The semiconductor provider reported $0.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.02. Cavium had a negative net margin of 7.00% and a positive return on equity of 14.07%. The business had revenue of $260.36 million for the quarter, compared to analysts’ expectations of $260.05 million. During the same quarter in the previous year, the firm posted $0.56 EPS. The business’s revenue for the quarter was up 15.1% compared to the same quarter last year. sell-side analysts expect that Cavium will post 2.13 EPS for the current fiscal year.

In related news, SVP Vincent P. Pangrazio sold 8,000 shares of the company’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $87.19, for a total value of $697,520.00. Following the completion of the transaction, the senior vice president now directly owns 54,577 shares in the company, valued at $4,758,568.63. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Anil Kumar Jain sold 16,059 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $87.51, for a total transaction of $1,405,323.09. Following the completion of the transaction, the vice president now owns 116,274 shares of the company’s stock, valued at $10,175,137.74. The disclosure for this sale can be found here. Insiders sold 353,962 shares of company stock valued at $31,361,100 over the last quarter. 4.65% of the stock is owned by company insiders.

Large investors have recently made changes to their positions in the stock. Omni Partners LLP purchased a new position in Cavium in the fourth quarter worth $30,098,000. Kassirer Asset Management Corp purchased a new position in Cavium in the fourth quarter worth $4,611,000. Carillon Tower Advisers Inc. purchased a new position in Cavium in the fourth quarter worth $36,031,000. US Bancorp DE grew its position in Cavium by 201.3% in the fourth quarter. US Bancorp DE now owns 1,657 shares of the semiconductor provider’s stock worth $139,000 after acquiring an additional 1,107 shares in the last quarter. Finally, Washington Capital Management Inc. purchased a new position in Cavium in the fourth quarter worth $369,000. Institutional investors own 92.11% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Cavium (CAVM) Cut to Sell at ValuEngine” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.thecerbatgem.com/2018/04/22/cavium-cavm-cut-to-sell-at-valuengine.html.

About Cavium

Cavium, Inc designs, develops, and markets semiconductor processors for intelligent and secure networks in the United States and internationally. The company offers integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage, and security applications.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Cavium (NASDAQ:CAVM)

Receive News & Ratings for Cavium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium and related companies with MarketBeat.com's FREE daily email newsletter.